Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Clin Oncol ; 7(5): 662-8, 1989 May.
Artigo em Inglês | MEDLINE | ID: mdl-2709091

RESUMO

Regional delivery of iododeoxyuridine (IdUrd) to patients with colorectal liver metastases was examined in a phase I study. The maximum-tolerated intraarterial (IA) dose (MTD) was 1,333 mg/m2/d administered continuously for 14 days. The dose-limiting toxicity was thrombocytopenia. Thrombocytopenia and leukopenia were correlated with the amount of IdUrd incorporated into DNA of peripheral granulocytes. In contrast to our experience with 5-fluorodeoxyuridine, there was no evidence of hepatobiliary toxicity. In 11 patients who received IA IdUrd alone, seven had a greater than or equal to 50% decrease in carcinoembryonic antigen (CEA) levels, with five having tumor volume reductions of 65%, 48%, 46%, 44%, and 27%. Thus, IA IdUrd alone has antitumor efficacy. Patients subsequently received IdUrd in combination with external beam radiation to a total dose of 2,400 cGy without acute local toxicity. In addition to these favorable clinical findings, we have previously shown that IdUrd is selectively incorporated into tumor DNA compared with normal liver in these patients. Further phase II evaluations of this approach are warranted.


Assuntos
Antineoplásicos/administração & dosagem , Neoplasias Colorretais/tratamento farmacológico , Idoxuridina/administração & dosagem , Neoplasias Hepáticas/secundário , Antineoplásicos/efeitos adversos , Neoplasias Colorretais/metabolismo , Neoplasias Colorretais/patologia , Terapia Combinada , DNA de Neoplasias/metabolismo , Avaliação de Medicamentos , Feminino , Doenças Hematológicas/induzido quimicamente , Artéria Hepática , Humanos , Idoxuridina/efeitos adversos , Idoxuridina/farmacocinética , Neoplasias Hepáticas/tratamento farmacológico , Masculino , Pessoa de Meia-Idade
2.
J Clin Endocrinol Metab ; 66(2): 294-300, 1988 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2828407

RESUMO

We describe a patient with an absent intestinal response to 1,25-dihydroxyvitamin D [1,25-(OH)2D] and the beneficial effects of treatment with high dose iv calcium infusion. The patient presented with severe rickets despite therapy with extraordinarily high doses of 1 alpha-hydroxyvitamin D3 or 1,25-(OH)2D3. Unidirectional intestinal fractional calcium absorption when he was not treated with any calciferol was 14% (normal, 20-70%), as measured with stable calcium isotopes; no increase in calcium absorption occurred when serum 1,25-(OH)2D levels were more than 50-fold elevated. Cultured skin fibroblasts contained no detectable 25-hydroxyvitamin D3-24-hydroxylase activity in response to 1,25-(OH)2D3 (10(-9)-10(-6) mol/L). High dose iv calcium infusions and oral phosphorus supplementation for 135 days improved or normalized biochemical parameters and resulted in radiographic healing of the rachitic lesions. We conclude that 1) this patient had no response to 1,25-(OH)2D3 in vivo and in vitro; 2) long term parenteral calcium infusions were effective therapy in managing the patient's severe resistance to 1,25-(OH)2D; and 3) stable calcium isotopes are useful for measuring low levels of fractional calcium absorption.


Assuntos
Calcitriol/fisiologia , Cálcio/uso terapêutico , Hipofosfatemia Familiar/tratamento farmacológico , Absorção Intestinal , Fosfatase Alcalina/sangue , Cálcio/administração & dosagem , Cálcio/farmacocinética , Pré-Escolar , Fibroblastos/efeitos dos fármacos , Humanos , Hipofosfatemia Familiar/genética , Masculino , Fósforo/administração & dosagem , Fósforo/uso terapêutico , Pele/efeitos dos fármacos
3.
Medicine (Baltimore) ; 67(4): 231-47, 1988 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-3393078

RESUMO

Several fungal species are capable of causing either noninvasive fungal sinusitis or invasive disease characterized by erosion into mucosa, submucosa, bone, and deeper contiguous structures. The diagnosis of invasive infection becomes firmly established only after histologic demonstration of hyphae within these areas. Computerized tomography and magnetic resonance imaging can assist in distinguishing between invasive and noninvasive disease by outlining bone and adjacent structures. The 2 forms of chronic fungal sinusitis mandate different therapeutic approaches. While patients with noninvasive infection require only surgical removal of hyphal masses and the reestablishment of sinus drainage for a successful outcome, invasive infection necessitates not only thorough surgical debridement of abnormal tissues but may also require prolonged antifungal chemotherapy. All patients require long-term follow-up. Even the combined approach has sometimes proven disappointing during long-term follow-up of disease, rendering investigational therapy appropriate in some patients.


Assuntos
Micoses , Sinusite , Adulto , Doença Crônica , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Micoses/diagnóstico , Micoses/diagnóstico por imagem , Micoses/patologia , Seios Paranasais/anatomia & histologia , Seios Paranasais/diagnóstico por imagem , Seios Paranasais/patologia , Sinusite/diagnóstico , Sinusite/diagnóstico por imagem , Sinusite/patologia , Tomografia Computadorizada por Raios X
4.
J Nucl Med ; 34(2): 173-9, 1993 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8381474

RESUMO

Iodine-131-metaiodobenzylguanidine (MIBG) scintigraphy, transmission computed tomography and magnetic resonance imaging were used to evaluate 36 patients with clinically suspected functioning paragangliomas. The patients were divided into two groups. In Group 1 (n = 21), studied before surgery, patients mainly had benign adrenal disease. In Group 2 (n = 15), studied after surgery, patients frequently had malignant or extra-adrenal tumors. In Group 1, transmission computed tomography and magnetic resonance imaging were more sensitive (100% for both) than MIBG scintigraphy (82%), which, however, was the most specific (100%). In Group 2, MIBG scintigraphy and magnetic resonance imaging were more sensitive (83% for both) than transmission computed tomography (75%), but MIBG was again the most specific (100%). Thus, all three were complementary modalities for localizing paragangliomas both preoperatively and postoperatively. MIBG imaging is indicated for both groups but it is especially recommended for postsurgical patients with recurrence because the disease is often malignant or extra-adrenal.


Assuntos
Iodobenzenos , Imageamento por Ressonância Magnética , Paraganglioma/diagnóstico por imagem , Tomografia Computadorizada por Raios X , 3-Iodobenzilguanidina , Neoplasias das Glândulas Suprarrenais/diagnóstico , Neoplasias das Glândulas Suprarrenais/diagnóstico por imagem , Neoplasias das Glândulas Suprarrenais/cirurgia , Adulto , Feminino , Humanos , Radioisótopos do Iodo , Masculino , Pessoa de Meia-Idade , Paraganglioma/diagnóstico , Paraganglioma/cirurgia , Paraganglioma Extrassuprarrenal/diagnóstico , Paraganglioma Extrassuprarrenal/diagnóstico por imagem , Paraganglioma Extrassuprarrenal/cirurgia , Cintilografia
8.
Radiology ; 169(2): 387-9, 1988 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3051115

RESUMO

Skin thickening and subcutaneous air were detected at ultrasound (US) of the scrotum in a patient with normal-appearing testicles and signs and symptoms suggestive of an acute inflammatory process, such as epidydimitis or orchitis. The patient was found to have Fournier gangrene. In more advanced cases, US can demonstrate that this skin thickening and subcutaneous air extends posteriorly to include the perineum and buttocks. Because of the high mortality of this mixed anaerobic and aerobic infection, it is important to recognize Fournier gangrene early so that the correct surgical and medical treatment can be promptly instituted. To the authors' knowledge, this is the first description of the US characteristics of Fournier gangrene.


Assuntos
Fasciite/diagnóstico , Escroto/patologia , Ultrassonografia , Gangrena , Doenças dos Genitais Masculinos/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade , Períneo/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA